Changes in Testing and Treatment Methods in Osteoporosis Care
Takashi Nagai1,2, Koji Ishikawa2, Koki Tsuchiya2
1Department of Rehabilitation Medicine, Showa University School of Medicine, Tokyo, Japan.
Physicians increasingly use bone density scans and blood tests for osteoporosis diagnosis. Treatment trends shifted towards medications that rapidly increase bone mineral density, improving fracture prevention in bedridden patients.
Area of Science:
- Orthopedics
- Endocrinology
- Geriatrics
Background:
- Osteoporosis treatment is vital for fracture prevention, especially in vulnerable bedridden populations.
- Understanding physician diagnostic and treatment trends is key to optimizing patient care.
Purpose of the Study:
- To investigate the 5-year trend in osteoporosis diagnostic and treatment preferences among physicians.
- To assess changes in the utilization of bone mineral density measurements and bone metabolic markers.
- To identify shifts in the prescription patterns of osteoporosis pharmacotherapies.
Main Methods:
- A comparative questionnaire survey of hypothetical clinical cases administered in 2015 and 2020.
- Targeting physicians in local clinics and hospitals, with a focus on orthopaedic surgeons (n=74).
- Analysis of responses regarding diagnostic tests and therapeutic agent choices.
Main Results:
- Significant increase in physician preference for bone mineral density measurements (lumbar spine and hip).
- Marked rise in the use of bone metabolic markers (NTX, P1NP, TRACP-5b) due to convenience and reliability.
- Shift in pharmacotherapy from bisphosphonates towards parathyroid hormone and romosozumab for rapid bone density enhancement.
Conclusions:
- Physician adoption of bone density testing and metabolic markers for osteoporosis diagnosis has grown.
- There is a clear trend towards early use of potent anabolic agents to rapidly improve bone mineral density.
- These shifts indicate an evolving approach to osteoporosis management, aiming for earlier and more effective fracture risk reduction.
More Related Videos
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
09:02Cortical Bone Assessment Using Ultrasonic Guided Waves: A Reproducibility Study in a Healthy Population
Published on: January 31, 2025
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling
Osteoclasts in Bone Remodeling
Fractures: Bone Repair
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
